Breaking News

The government is shut down & the first ‘most-favored nation’ deal is here

October 1, 2025
theresa-g-avatar-small - light bg
Morning Rounds Writer and Reporter
Good morning. The government is shut down, but the First Opinion Podcast is back. Take a listen.

one big number

32,460

That's how many federal health workers are set to be furloughed as the government shuts down today, after the Senate failed to pass a temporary spending package that would have funded the government until the end of November. Senate Democrats refused to back the funding bill without an extension to Affordable Care Act subsidies and a restoration of cut Medicaid funds. On top of the furloughs, CDC communications will be impeded and no new patients will be admitted to the NIH clinical center. Read more from STAT's Chelsea Cirruzzo on the impact.


art of the deal?

The first 'most-favored nation' deal is here

As the government neared shutdown yesterday, President Trump announced that Pfizer has agreed to offer lower prices on its drugs to the Medicaid program and in direct-to-consumer sales for patients without insurance. The company also agreed to launch new medicines at prices "at parity" with those in other countries; in return, as long as it continues to invest in U.S. manufacturing, the company will not have to pay certain tariffs on drugs imported into the U.S. 

"I think this is one of the biggest medical announcements that this office has ever made," Trump said about the agreement, which he called the first in a series of deals to secure cheaper prescription medicines for the U.S. But experts aren't so sure, pointing out to STAT's Elaine Chen that many details are still unknown, such as what the most-favored nations prices will be and how the plans will be implemented. Read more from Elaine on whether or not experts believe the move will actually change the status quo. 

While how this will play out for patients is yet to be seen, STAT's Matthew Herper writes that one thing was clear in the Oval Office as the deal was announced: Everyone in the room was convinced this was the best deal they could get. To Matt, perhaps the most notable part of the event was something Pfizer CEO Albert Bourla said: "But most of all, Mr. President, I want to thank you for your leadership and for your friendship." Friendship? More like threats and a tense negotiation, writes Matt.


autism

Q&A with a researcher who has studied leucovorin

Before most of us had ever heard about leucovorin, the autism community was discussing its potential. Since the early 2000s, some parents have sworn the dietary supplement improved their autistic children's ability to speak and communicate, and some doctors would prescribe a branded drug — Wellcovorin — with the same key ingredient, called folinic acid.

The evidence supporting this mostly comes from small studies showing modest improvement in reducing certain autism symptoms. "I have not seen a remarkable response to leucovorin/folinic acid, but I think it has a good place in treatment of ASD," Robert Hendren, a retired autism researcher who conducted one of those studies, told STAT's O. Rose Broderick. "It's not gonna cure autism." Read their conversation on both the science and the politics around the drug. 



science

A new recipe for human reproduction

A human somatic cell nuclear transfer oocyte with visible spindle (bright spot inside) before fertilization

Mitalipov laboratory 

In 2022, researchers at Oregon Health & Science University reported the birth of three healthy mouse pups from eggs created in the lab with DNA from the skin cells of adult mice. Since then, the team has been attempting to adapt their methods to create human embryos. If they're successful, it could open new avenues to treating infertility, preventing heritable diseases, and allowing same-sex couples to have genetically related children. But in a new research update, the team disclosed they've been mostly unsuccessful so far.

"It kind of partially works, and partially doesn't," said embryologist Shoukhrat Mitalipov, who is leading the research, acknowledging the technology requires refinement before it could move into clinical testing. Still, he's optimistic about the future, and he has reason to be — Mitalipov pioneered the technique behind three-parent IVF. Read more from STAT's Megan Molteni on the promise of in-vitro gametogenesis, and what science has achieved so far.


public health

The danger of multiple Covid infections for kids

Kids and teens who got Covid twice between January 2022 and October 2023 (dominated by the Omicron wave) were almost twice as likely to develop long Covid as compared to those who were infected once during that time. That's according to a study published yesterday in the Lancet Infectious Disease that analyzed data from 40 children's hospitals and more than 465,000 patients under the age of 21. After one infection, 904 children per million developed long Covid within six weeks. But among those who had a second infection, the rate rose to 1,884 per million.

The elevated risk after reinfection was consistent regardless of age, gender, race, weight, how serious the first infection was, and the patient's vaccination status. On that last one — the authors emphasize that the results still indicate the importance of vaccination for children, as it's the best way to prevent infection in the first place, as well as reinfections. (In the data, unvaccinated kids made up about three quarters of both first and second infections.) More research on the risks and consequences of long Covid is necessary.  

In related news: Neither HHS secretary Robert F. Kennedy Jr. nor his top deputy have signed off on ACIP's new Covid vaccine recommendations, leaving states unable to order vaccines for low-income children. Read more from STAT's Anil Oza and Chelsea Cirruzzo.


policy

Two unrelated FDA actions, explained

FDA Commissioner Marty Makary announced yesterday a new initiative to "increase voluntary compliance" from retailers selling illegal vape products, which have historically been underregulated by the agency. The initiative involves sending education materials to retailers on which products are legal, who can buy them, and FDA resources. It's part of a larger pattern by the Trump administration, which has continually demanded voluntary action from food companies, pharma, and hospitals — offering incentives for those who comply and promising harsh penalties for those who don't.

And one other thing, that I'm sorry to even bring up again: Screwworms. The FDA yesterday approved an injectable drug for cattle that prevents and treats New World screwworm infections. It's a rare infection in humans, so concerns about its spread mainly revolve around livestock. An outbreak in Central America has been traveling north, and as of earlier this week, the latest livestock infection was less than 60 miles from the U.S.-Mexico border, per the New York Times. Read more on the basics. 


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • Pasta meals from Trader Joe's and Walmart may be linked to a deadly listeria outbreak, NPR

  • Indivior to stop marketing Opvee, controversial overdose-reversal medication, STAT
  • Medicaid work requirements don't boost employment, study shows, New York Times
  • First Opinion: Why the human workflow is health AI's biggest, costliest problem, STAT

Thanks for reading! More next time,


Enjoying Morning Rounds? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments